Đang chuẩn bị liên kết để tải về tài liệu:
HIPECT4: Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Local relapse and peritoneal carcinomatosis (PC) for pT4 colon cancer is estimated in 15,6% and 36,7% for 12 months and 36 months from surgical resection respectively, achieving a 5 years overall survival of 6%. | HIPECT4 Multicentre randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy HIPEC with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

TÀI LIỆU LIÊN QUAN

HIPECT4: Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma